Carbimazole
 | This article relies largely or entirely on a single source. |
 | |
| Clinical data | |
|---|---|
| Trade names | Neo-Mercazole, Anti-Thyrox, etc. |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 85% |
| Elimination half-life | 5.3h |
| Excretion | Kidney >90% |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| ECHA InfoCard | 100.040.762 |
| (verify) | |
Carbimazole (brand names AFT-Carbimazole (NZ), Anti-Thyrox (India), and others[2]) is a medicine used to treat an overactive thyroid (hyperthyroidism).[3] Carbimazole helps to ease symptoms by reducing the amount of hormones the thyroid produces.[3]
The thyroid controls things like heart rate and body temperature. Symptoms from when it makes too many hormones can include weight loss, mood swings, and feeling irritable.[3]
Sometimes the doctor will prescribe carbimazole together with a beta blocker.[3] This can help symptoms such as feeling jittery or anxious or having a fast heartbeat.[3]
Related pages
[change | change source]References
[change | change source]- ↑ "Updates to the Prescribing Medicines in Pregnancy database". Therapeutic Goods Administration (TGA). 12 May 2022. Retrieved 13 May 2022.
- ↑ "Carbimazole (International database)". Drugs.com. Retrieved 2024-05-30.
- ↑ 3.0 3.1 3.2 3.3 3.4 "Carbimazole: medicine for treating overactive thyroid (hyperthyroidism)". nhs.uk. 2021-08-04. Retrieved 2024-05-30.